 | • レポートコード：MRC2-11QY04126 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は卵巣がんのグローバル市場について調査・分析したレポートです。種類別（手術、化学療法、放射線、生物学的療法）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別卵巣がんの競争状況、市場シェア ・世界の卵巣がん市場：種類別市場規模 2015年-2020年（手術、化学療法、放射線、生物学的療法） ・世界の卵巣がん市場：種類別市場規模予測 2021年-2026年（手術、化学療法、放射線、生物学的療法） ・世界の卵巣がん市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界の卵巣がん市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米の卵巣がん市場分析：米国、カナダ ・ヨーロッパの卵巣がん市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの卵巣がん市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の卵巣がん市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの卵巣がん市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bristol Myers Squibb、Eli Lilly、GlaxoSmithKline、Janssen Pharmaceuticals、Novogen、Genentech、Aetera Zenteris、Boehringer Ingelheim、Roche ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Ovarian cancer is a type of cancer that begins in the ovaries. Ovarian cancer is the most common type of cancer among women. Epithelial tumor, stromal tumor and germ cell tumors are the type of ovarian cancer.
North America dominates the global market for ovarian cancer due to large number of aging population. Asia is expected to show high growth rates in the next five years in the global ovarian cancer market. China and India are expected to be the fastest growing ovarian cancer markets in Asia-Pacific region. Some of the key driving forces for ovarian cancer market in emerging countries are rise in healthcare expenditure, large pool of patients and rising government funding.
Market Analysis and Insights: Global Ovarian Cancer Market
The global Ovarian Cancer market size is projected to reach US$ 1804.2 million by 2026, from US$ 1637 million in 2020, at a CAGR of 9.5%% during 2021-2026.
Global Ovarian Cancer Scope and Market Size
Ovarian Cancer market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ovarian Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Bristol Myers Squibb
Eli Lilly
GlaxoSmithKline
Janssen Pharmaceuticals
Novogen
Genentech
Aetera Zenteris
Boehringer Ingelheim
Roche
Market segment by Type, the product can be split into
Surgery
Chemotherapy
Radiation
Biological Therapy
Market segment by Application, split into
Hospitals
Clinics
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Ovarian Cancer Revenue
1.4 Market by Type
1.4.1 Global Ovarian Cancer Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Surgery
1.4.3 Chemotherapy
1.4.4 Radiation
1.4.5 Biological Therapy
1.5 Market by Application
1.5.1 Global Ovarian Cancer Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Ovarian Cancer Market Perspective (2015-2026)
2.2 Global Ovarian Cancer Growth Trends by Regions
2.2.1 Ovarian Cancer Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Ovarian Cancer Historic Market Share by Regions (2015-2020)
2.2.3 Ovarian Cancer Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Ovarian Cancer Market Growth Strategy
2.3.6 Primary Interviews with Key Ovarian Cancer Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Ovarian Cancer Players by Market Size
3.1.1 Global Top Ovarian Cancer Players by Revenue (2015-2020)
3.1.2 Global Ovarian Cancer Revenue Market Share by Players (2015-2020)
3.1.3 Global Ovarian Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Ovarian Cancer Market Concentration Ratio
3.2.1 Global Ovarian Cancer Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Ovarian Cancer Revenue in 2019
3.3 Ovarian Cancer Key Players Head office and Area Served
3.4 Key Players Ovarian Cancer Product Solution and Service
3.5 Date of Enter into Ovarian Cancer Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Ovarian Cancer Historic Market Size by Type (2015-2020)
4.2 Global Ovarian Cancer Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Ovarian Cancer Market Size by Application (2015-2020)
5.2 Global Ovarian Cancer Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Ovarian Cancer Market Size (2015-2020)
6.2 Ovarian Cancer Key Players in North America (2019-2020)
6.3 North America Ovarian Cancer Market Size by Type (2015-2020)
6.4 North America Ovarian Cancer Market Size by Application (2015-2020)
7 Europe
7.1 Europe Ovarian Cancer Market Size (2015-2020)
7.2 Ovarian Cancer Key Players in Europe (2019-2020)
7.3 Europe Ovarian Cancer Market Size by Type (2015-2020)
7.4 Europe Ovarian Cancer Market Size by Application (2015-2020)
8 China
8.1 China Ovarian Cancer Market Size (2015-2020)
8.2 Ovarian Cancer Key Players in China (2019-2020)
8.3 China Ovarian Cancer Market Size by Type (2015-2020)
8.4 China Ovarian Cancer Market Size by Application (2015-2020)
9 Japan
9.1 Japan Ovarian Cancer Market Size (2015-2020)
9.2 Ovarian Cancer Key Players in Japan (2019-2020)
9.3 Japan Ovarian Cancer Market Size by Type (2015-2020)
9.4 Japan Ovarian Cancer Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Ovarian Cancer Market Size (2015-2020)
10.2 Ovarian Cancer Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Ovarian Cancer Market Size by Type (2015-2020)
10.4 Southeast Asia Ovarian Cancer Market Size by Application (2015-2020)
11 India
11.1 India Ovarian Cancer Market Size (2015-2020)
11.2 Ovarian Cancer Key Players in India (2019-2020)
11.3 India Ovarian Cancer Market Size by Type (2015-2020)
11.4 India Ovarian Cancer Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Ovarian Cancer Market Size (2015-2020)
12.2 Ovarian Cancer Key Players in Central & South America (2019-2020)
12.3 Central & South America Ovarian Cancer Market Size by Type (2015-2020)
12.4 Central & South America Ovarian Cancer Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Bristol Myers Squibb
13.1.1 Bristol Myers Squibb Company Details
13.1.2 Bristol Myers Squibb Business Overview
13.1.3 Bristol Myers Squibb Ovarian Cancer Introduction
13.1.4 Bristol Myers Squibb Revenue in Ovarian Cancer Business (2015-2020))
13.1.5 Bristol Myers Squibb Recent Development
13.2 Eli Lilly
13.2.1 Eli Lilly Company Details
13.2.2 Eli Lilly Business Overview
13.2.3 Eli Lilly Ovarian Cancer Introduction
13.2.4 Eli Lilly Revenue in Ovarian Cancer Business (2015-2020)
13.2.5 Eli Lilly Recent Development
13.3 GlaxoSmithKline
13.3.1 GlaxoSmithKline Company Details
13.3.2 GlaxoSmithKline Business Overview
13.3.3 GlaxoSmithKline Ovarian Cancer Introduction
13.3.4 GlaxoSmithKline Revenue in Ovarian Cancer Business (2015-2020)
13.3.5 GlaxoSmithKline Recent Development
13.4 Janssen Pharmaceuticals
13.4.1 Janssen Pharmaceuticals Company Details
13.4.2 Janssen Pharmaceuticals Business Overview
13.4.3 Janssen Pharmaceuticals Ovarian Cancer Introduction
13.4.4 Janssen Pharmaceuticals Revenue in Ovarian Cancer Business (2015-2020)
13.4.5 Janssen Pharmaceuticals Recent Development
13.5 Novogen
13.5.1 Novogen Company Details
13.5.2 Novogen Business Overview
13.5.3 Novogen Ovarian Cancer Introduction
13.5.4 Novogen Revenue in Ovarian Cancer Business (2015-2020)
13.5.5 Novogen Recent Development
13.6 Genentech
13.6.1 Genentech Company Details
13.6.2 Genentech Business Overview
13.6.3 Genentech Ovarian Cancer Introduction
13.6.4 Genentech Revenue in Ovarian Cancer Business (2015-2020)
13.6.5 Genentech Recent Development
13.7 Aetera Zenteris
13.7.1 Aetera Zenteris Company Details
13.7.2 Aetera Zenteris Business Overview
13.7.3 Aetera Zenteris Ovarian Cancer Introduction
13.7.4 Aetera Zenteris Revenue in Ovarian Cancer Business (2015-2020)
13.7.5 Aetera Zenteris Recent Development
13.8 Boehringer Ingelheim
13.8.1 Boehringer Ingelheim Company Details
13.8.2 Boehringer Ingelheim Business Overview
13.8.3 Boehringer Ingelheim Ovarian Cancer Introduction
13.8.4 Boehringer Ingelheim Revenue in Ovarian Cancer Business (2015-2020)
13.8.5 Boehringer Ingelheim Recent Development
13.9 Roche
13.9.1 Roche Company Details
13.9.2 Roche Business Overview
13.9.3 Roche Ovarian Cancer Introduction
13.9.4 Roche Revenue in Ovarian Cancer Business (2015-2020)
13.9.5 Roche Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Ovarian Cancer Key Market Segments
Table 2. Key Players Covered: Ranking by Ovarian Cancer Revenue
Table 3. Ranking of Global Top Ovarian Cancer Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Ovarian Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Surgery
Table 6. Key Players of Chemotherapy
Table 7. Key Players of Radiation
Table 8. Key Players of Biological Therapy
Table 9. Global Ovarian Cancer Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Ovarian Cancer Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Ovarian Cancer Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Ovarian Cancer Market Share by Regions (2015-2020)
Table 13. Global Ovarian Cancer Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Ovarian Cancer Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Ovarian Cancer Market Growth Strategy
Table 19. Main Points Interviewed from Key Ovarian Cancer Players
Table 20. Global Ovarian Cancer Revenue by Players (2015-2020) (Million US$)
Table 21. Global Ovarian Cancer Market Share by Players (2015-2020)
Table 22. Global Top Ovarian Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ovarian Cancer as of 2019)
Table 23. Global Ovarian Cancer by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Ovarian Cancer Product Solution and Service
Table 26. Date of Enter into Ovarian Cancer Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Ovarian Cancer Market Size by Type (2015-2020) (Million US$)
Table 29. Global Ovarian Cancer Market Size Share by Type (2015-2020)
Table 30. Global Ovarian Cancer Revenue Market Share by Type (2021-2026)
Table 31. Global Ovarian Cancer Market Size Share by Application (2015-2020)
Table 32. Global Ovarian Cancer Market Size by Application (2015-2020) (Million US$)
Table 33. Global Ovarian Cancer Market Size Share by Application (2021-2026)
Table 34. North America Key Players Ovarian Cancer Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Ovarian Cancer Market Share (2019-2020)
Table 36. North America Ovarian Cancer Market Size by Type (2015-2020) (Million US$)
Table 37. North America Ovarian Cancer Market Share by Type (2015-2020)
Table 38. North America Ovarian Cancer Market Size by Application (2015-2020) (Million US$)
Table 39. North America Ovarian Cancer Market Share by Application (2015-2020)
Table 40. Europe Key Players Ovarian Cancer Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Ovarian Cancer Market Share (2019-2020)
Table 42. Europe Ovarian Cancer Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Ovarian Cancer Market Share by Type (2015-2020)
Table 44. Europe Ovarian Cancer Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Ovarian Cancer Market Share by Application (2015-2020)
Table 46. China Key Players Ovarian Cancer Revenue (2019-2020) (Million US$)
Table 47. China Key Players Ovarian Cancer Market Share (2019-2020)
Table 48. China Ovarian Cancer Market Size by Type (2015-2020) (Million US$)
Table 49. China Ovarian Cancer Market Share by Type (2015-2020)
Table 50. China Ovarian Cancer Market Size by Application (2015-2020) (Million US$)
Table 51. China Ovarian Cancer Market Share by Application (2015-2020)
Table 52. Japan Key Players Ovarian Cancer Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Ovarian Cancer Market Share (2019-2020)
Table 54. Japan Ovarian Cancer Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Ovarian Cancer Market Share by Type (2015-2020)
Table 56. Japan Ovarian Cancer Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Ovarian Cancer Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Ovarian Cancer Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Ovarian Cancer Market Share (2019-2020)
Table 60. Southeast Asia Ovarian Cancer Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Ovarian Cancer Market Share by Type (2015-2020)
Table 62. Southeast Asia Ovarian Cancer Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Ovarian Cancer Market Share by Application (2015-2020)
Table 64. India Key Players Ovarian Cancer Revenue (2019-2020) (Million US$)
Table 65. India Key Players Ovarian Cancer Market Share (2019-2020)
Table 66. India Ovarian Cancer Market Size by Type (2015-2020) (Million US$)
Table 67. India Ovarian Cancer Market Share by Type (2015-2020)
Table 68. India Ovarian Cancer Market Size by Application (2015-2020) (Million US$)
Table 69. India Ovarian Cancer Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Ovarian Cancer Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Ovarian Cancer Market Share (2019-2020)
Table 72. Central & South America Ovarian Cancer Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Ovarian Cancer Market Share by Type (2015-2020)
Table 74. Central & South America Ovarian Cancer Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Ovarian Cancer Market Share by Application (2015-2020)
Table 76. Bristol Myers Squibb Company Details
Table 77. Bristol Myers Squibb Business Overview
Table 78. Bristol Myers Squibb Product
Table 79. Bristol Myers Squibb Revenue in Ovarian Cancer Business (2015-2020) (Million US$)
Table 80. Bristol Myers Squibb Recent Development
Table 81. Eli Lilly Company Details
Table 82. Eli Lilly Business Overview
Table 83. Eli Lilly Product
Table 84. Eli Lilly Revenue in Ovarian Cancer Business (2015-2020) (Million US$)
Table 85. Eli Lilly Recent Development
Table 86. GlaxoSmithKline Company Details
Table 87. GlaxoSmithKline Business Overview
Table 88. GlaxoSmithKline Product
Table 89. GlaxoSmithKline Revenue in Ovarian Cancer Business (2015-2020) (Million US$)
Table 90. GlaxoSmithKline Recent Development
Table 91. Janssen Pharmaceuticals Company Details
Table 92. Janssen Pharmaceuticals Business Overview
Table 93. Janssen Pharmaceuticals Product
Table 94. Janssen Pharmaceuticals Revenue in Ovarian Cancer Business (2015-2020) (Million US$)
Table 95. Janssen Pharmaceuticals Recent Development
Table 96. Novogen Company Details
Table 97. Novogen Business Overview
Table 98. Novogen Product
Table 99. Novogen Revenue in Ovarian Cancer Business (2015-2020) (Million US$)
Table 100. Novogen Recent Development
Table 101. Genentech Company Details
Table 102. Genentech Business Overview
Table 103. Genentech Product
Table 104. Genentech Revenue in Ovarian Cancer Business (2015-2020) (Million US$)
Table 105. Genentech Recent Development
Table 106. Aetera Zenteris Company Details
Table 107. Aetera Zenteris Business Overview
Table 108. Aetera Zenteris Product
Table 109. Aetera Zenteris Revenue in Ovarian Cancer Business (2015-2020) (Million US$)
Table 110. Aetera Zenteris Recent Development
Table 111. Boehringer Ingelheim Business Overview
Table 112. Boehringer Ingelheim Product
Table 113. Boehringer Ingelheim Company Details
Table 114. Boehringer Ingelheim Revenue in Ovarian Cancer Business (2015-2020) (Million US$)
Table 115. Boehringer Ingelheim Recent Development
Table 116. Roche Company Details
Table 117. Roche Business Overview
Table 118. Roche Product
Table 119. Roche Revenue in Ovarian Cancer Business (2015-2020) (Million US$)
Table 120. Roche Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ovarian Cancer Market Share by Type: 2020 VS 2026
Figure 2. Surgery Features
Figure 3. Chemotherapy Features
Figure 4. Radiation Features
Figure 5. Biological Therapy Features
Figure 6. Global Ovarian Cancer Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Ovarian Cancer Report Years Considered
Figure 11. Global Ovarian Cancer Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Ovarian Cancer Market Share by Regions: 2020 VS 2026
Figure 13. Global Ovarian Cancer Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Ovarian Cancer Market Share by Players in 2019
Figure 16. Global Top Ovarian Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ovarian Cancer as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Ovarian Cancer Revenue in 2019
Figure 18. North America Ovarian Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Ovarian Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Ovarian Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Ovarian Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Ovarian Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Ovarian Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Ovarian Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
卵巣がん遺伝子治療の世界市場（～2026年） Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…- 卵巣がん治療薬の世界市場（～2026年） Ovarian cancer, and its rising incidence rate, is a growing concern worldwide. Market players that are currently engaged in the development of drugs and therapies for ovarian cancer stand to benefit by observing the latest trends and pipeline competitor products. Market Analysis and Insights: Global…
- 転移性卵巣がん治療薬の世界市場（～2026年） Market Analysis and Insights: Global Metastatic Ovarian Cancer Drug Market The global Metastatic Ovarian Cancer Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Metastatic Ovarian Cancer Drug Scope and Market Size …
- 卵巣嚢腫の世界市場（～2026年） An ovarian cyst is a fluid-filled sac within the ovary. Often they cause no symptoms. Occasionally they may produce bloating, lower abdominal pain, or lower back pain. The majority of cysts are harmless. If the cyst either breaks open or causes twisting of the ovary, it may cause severe pain. This m…
- 多嚢胞性卵巣症候群治療の世界市場（～2026年） Polycystic ovary syndrome is a set of symptoms due to elevated androgens in females. Signs and symptoms of polycystic ovary syndrome nclude irregular or no menstrual periods, heavy periods, excess body and facial hair, acne, pelvic pain, difficulty getting pregnant and patches of thick, darker, velv…